Acasti Pharma Inc. announced that on May 8, 2023, the Company terminated the employment of Brian Ford, Chief Financial Officer. Mr. Ford will remain as interim Chief Financial Officer of the Company until June 30, 2023, subject to potential extension of that term by the Company. Under the terms of their employment arrangements Mr. Ford will receive severance payments.